Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mandana Mohyeddin Bonab"'
Autor:
Mandana Mohyeddin Bonab, Fatemeh Talebian, Aida Borzabadi, Vahideh Nasr, Azam Abedi Kooshlshahi, Fahime Anisie, Ronaz Haghshenas, Bita Shalbafan, Ehsan Janzamin, Saeed Shahbeigi
Publikováno v:
Translational Medicine Communications, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract Background Mesenchymal Stem Cells (MSCs) are multipotent cells with low immuonogenecity, and dynamic tissue repair potential, which explains the overwhelming attention they have attracted in regenerative therapy. One notable challenge in MSC
Externí odkaz:
https://doaj.org/article/c5d9bcd96439458fba7ed2199f6eb0c8
Autor:
Mohsen Saeidi, Ahmad Masoud, Yadollah Shakiba, Jamshid Hadjati, Mandana Mohyeddin Bonab, Mohammad Hossein Nicknam, Mostafa Latifpour, Behrooz Nikbin
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 12, Iss 1 (2013)
The Wharton’s jelly of the umbilical cord is believed to be a source of mesenchymal stem cells (MSCs) which can be therapeutically applied in degenerative diseases. In this study, we investigated the immunomodulatory effect of umbilical cord derive
Externí odkaz:
https://doaj.org/article/4ebb47ecd2874b79a95eb3874e5e04c0
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 10, Iss 3 (2011)
Multiple Sclerosis (MS) is an inflammatory demyelinating and neurodegenerative disorder of the central nervous system (CNS), which mainly affects young adults. Activated T lymphocytes promote the neuro-inflammatory cascade of MS by secreting pro-infl
Externí odkaz:
https://doaj.org/article/0c51e4938842400fb648edc32431fec1
Autor:
Bita Shalbafan, Fahime Anisie, Mandana Mohyeddin Bonab, Azam Abedi Kooshlshahi, Fatemeh Talebian, Aida Borzabadi, Vahideh Nasr, Saeed Shahbeigi, Ehsan Janzamin, Ronaz Haghshenas
Publikováno v:
Translational Medicine Communications, Vol 6, Iss 1, Pp 1-11 (2021)
Background Mesenchymal Stem Cells (MSCs) are multipotent cells with low immuonogenecity, and dynamic tissue repair potential, which explains the overwhelming attention they have attracted in regenerative therapy. One notable challenge in MSCs therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb820c96d242d2555f45af02a54641e4
https://doi.org/10.21203/rs.3.rs-379388/v1
https://doi.org/10.21203/rs.3.rs-379388/v1
Autor:
Abdorreza Naser Moghadasi, Mahsa Owji, Seyed Mohammad Baghbanian, Mandana Mohyeddin Bonab, Mohammad Ali Sahraian
Publikováno v:
Immunological investigations. 48(2)
Mesenchymal stem cells (MSCs) are a potential therapy for various diseases. Here, the results of intrathecal injection of MSCs in multiple sclerosis (MS) patients are reported.Four patients were enrolled in the study. Three were male and one was fema
Autor:
Nahid Beladi Moghadam, Katayoun Alikhani, Jamshid Lotfi, Saeideh Khorramnia, Sirous Jafarian, Samira Yadegari, Mohammad Reza Gheini, Sanaz Ahmadi Karvigh, Behrouz Nikbin, Mohammad Reza Motamed, Mansoureh Togha, Mohammad Ali Sahraian, Mohammad Hossien Harirchian, Aida Aghsaie, Mandana Mohyeddin Bonab, Seyed Massoud Hosseinian
Publikováno v:
Scopus-Elsevier
Despite updating knowledge and a growing number of medications for multiple sclerosis (MS), no definite treatment is available yet for patients suffering from progressive forms of the disease. Autologous bone marrow derived mesenchymal stem cell (BM-
Research on the pathogenesis of multiple sclerosis (MS) has almost exclusively been conducted on T cells, more specifically CD4+ T cells. This has been based on the theory that the most effective genetic factor in MS disease is located within the maj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf221d336bc05f3981af9ee6fb99425d
https://doi.org/10.1016/b978-0-12-800763-1.00003-8
https://doi.org/10.1016/b978-0-12-800763-1.00003-8
Autor:
Jonathan S. Alexander, Omar Al-Louzi, Yasunobu Arima, Toru Atsumi, Hidenori Bando, Felix Becker, Mandana Mohyeddin Bonab, Yesica Campos, Roxana O. Carare, Bogoljub Ciric, Fariba Dehghanian, Aleksandar Denic, Bénédicte Dubois, Ian Galea, Steven Gangloff, Ravindra Kumar Garg, Eduardo Gonzalez-Toledo, An Goris, Cheryl A. Hawkes, Kelly Hilven, Zohreh Hojati, Eric S. Huseby, S.L. Jaffe, Vijaykumar Javalkar, Jing-Jing Jiang, Daisuke Kamimura, Maryam Kay, Channa Kolb, Neeraj Kumar, Claudia F. Lucchinetti, Hardeep Singh Malhotra, Ashutosh Mangalam, Jeanie McGee, Jie Meng, Alireza Minagar, Masaaki Murakami, Mohammed Nadeem, Behrouz Nikbin, Bardia Nourbakhsh, Hideki Ogura, Seiichi Omura, Istvan Pirko, Bogdan F. Gh. Popescu, Murali Ramanathan, Javad Rasouli, Abdolmohamad Rostami, Lavannya Sabharwal, Shiv Saidha, Vasu Saini, Fumitaka Sato, Yadollah Shakiba, William Sheremata, Emily V. Stevenson, Fatemeh Talebian, Ikuo Tsunoda, Emmanuelle Waubant, Bianca Weinstock-Guttman, Roy O. Weller, Bharath Wootla, J. Winny Yun, Robert Zivadinov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::087d44867a21f779ec77167ee946994d
https://doi.org/10.1016/b978-0-12-800763-1.01002-2
https://doi.org/10.1016/b978-0-12-800763-1.01002-2
Multiple sclerosis (MS) is predominantly considered an immune-mediated chronic disease, with complicated pathogenesis and clinical signs of paralysis. MS is an inflammatory disease of the central nervous system in which T lymphocytes show a second ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f753ae2cf1d3fafe25dd06edbce46c0f
https://doi.org/10.1016/b978-0-12-800763-1.00017-8
https://doi.org/10.1016/b978-0-12-800763-1.00017-8
Autor:
Mohammad Mehdi Bagheri, Aliakbar Zeinaloo, Maryam Monajemzadeh, Keyhan Sayadpour Zanjani, Mandana Mohyeddin-Bonab, Mohammad Hossein Arjmandnia
Publikováno v:
Pediatric Transplantation. 15:E183-E186
Relatively high prevalence of dilated cardiomyopathy in children, unfavorable response to traditional drug therapy, and limitations in heart transplantation call for new therapeutic options. Stem cell therapy can be promising in children suffering fr